Trials / Sponsors / Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer EGFR Mutation Positive Non-small Cell Lung Cancer, EGFR Mutated Non-small Cell Lung Cancer Patients | Phase 1 | 2025-12-18 |
| Recruiting | A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer | Phase 1 | 2023-10-26 |
| Active Not Recruiting | A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Ca Advanced Solid Tumor, Ovarian Cancer, Ovarian Clear Cell Carcinoma | Phase 1 | 2021-12-31 |